Revenues, Recognition and Allowances (Tables)

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenues

Net revenues for the three months ended March 31, 2021 and 2020 are as follows:

	Three months ended March 31,
	2021		2020
Company product sales	$	10,595	$	7,139
Contract manufacturing sales	818		197
Research and development services and other income	175		111
Revenue, net	$	11,588	$	7,447

Disaggregated information for the Company product sales revenue has been recognized in the accompanying unaudited interim Condensed Consolidated Statements of Operations and is presented below according to product type:

	Three months ended March 31,
Company Product Sales	2021		2020
Topical	$	7,020	$	5,380
Injectables	3,575		1,759
Total	$	10,595	$	7,139

Schedule of Accounts, Notes, Loans and Financing Receivable

The Company's adjustments for the deductions to gross product sales are as follows:

	Three months ended March 31,
	2021		2020
Gross product sales	$	32,848	$	23,166
Deduction to gross product sales:
Chargebacks and billbacks	16,980		11,955
Wholesaler fees for service	1,359		1,142
Sales discounts and other allowances	3,914		2,930
Total reduction to gross product sales	$	22,253	$	16,027
Company product sales, net	$	10,595	$	7,139